Which patients, in your view, based on the ODYSSEY Outcomes and FOURIER trials, do you want to drive below the LDL-C “threshold” of 70 mg/dL? What is your rationale and how do you select your patients and achieve your targets in the real world?

Which patients, in your view, based on the ODYSSEY Outcomes and FOURIER trials, do you want to drive below the LDL-C “threshold” of 70 mg/dL? What is your rationale and how do you select your patients and achieve your targets in the real world?

CLICK HERE FOR CME CREDIT

Which patients, in your view, based on the ODYSSEY Outcomes and FOURIER trials, do you want to drive below the LDL-C “threshold” of 70 mg/dL? What is your rationale and how do you select your patients and achieve your targets in the real world?

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Lipidologist and Atherosclerosis Specialist's Perspective

Presenter

Michael J. Blaha, MD, MPH

Michael J. Blaha, MD, MPH

Director of Clinical Research Ciccarone Center for the Prevention of Heart Disease

Director of Clinical Research
Ciccarone Center for the Prevention of Heart Disease
Associate Professor of Medicine
Johns Hopkins School of Medicine
Baltimore, MD